H
Hyphens Pharma International Ltd
SGX:1J5
Hyphens Pharma International Ltd
SGX:1J5
Price:
0.285
SGD
Market Closed
Market Cap:
88.1m
SGD
Balance Sheet
Balance Sheet Decomposition
Hyphens Pharma International Ltd
Hyphens Pharma International Ltd
| Current Assets | 101.6m |
| Cash & Short-Term Investments | 18.8m |
| Receivables | 46m |
| Other Current Assets | 36.8m |
| Non-Current Assets | 30.2m |
| PP&E | 5.1m |
| Intangibles | 24.9m |
| Other Non-Current Assets | 213k |
Balance Sheet
Hyphens Pharma International Ltd
Hyphens Pharma International Ltd
Currency: SGD
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
14
|
13
|
12
|
22
|
26
|
28
|
19
|
36
|
23
|
23
|
|
| Cash Equivalents |
14
|
13
|
12
|
22
|
26
|
28
|
19
|
36
|
23
|
23
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Receivables |
15
|
20
|
24
|
30
|
29
|
24
|
29
|
31
|
40
|
45
|
|
| Accounts Receivables |
15
|
20
|
24
|
30
|
29
|
23
|
28
|
30
|
40
|
45
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Inventory |
6
|
9
|
13
|
11
|
11
|
17
|
25
|
21
|
26
|
34
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
|
| Total Current Assets |
35
|
42
|
49
|
64
|
67
|
69
|
74
|
90
|
92
|
106
|
|
| PP&E Net |
1
|
1
|
1
|
3
|
6
|
5
|
4
|
3
|
5
|
5
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
5
|
4
|
3
|
5
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
4
|
6
|
8
|
6
|
0
|
|
| Intangible Assets |
1
|
9
|
9
|
8
|
7
|
8
|
5
|
6
|
8
|
25
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
13
|
13
|
15
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
13
|
13
|
15
|
0
|
|
| Total Assets |
36
N/A
|
53
+45%
|
60
+13%
|
75
+26%
|
80
+7%
|
81
+2%
|
99
+22%
|
114
+15%
|
121
+6%
|
136
+12%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
19
|
25
|
35
|
31
|
31
|
28
|
34
|
35
|
44
|
44
|
|
| Short-Term Debt |
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
2
|
3
|
0
|
1
|
7
|
2
|
2
|
12
|
|
| Other Current Liabilities |
1
|
1
|
1
|
1
|
3
|
1
|
2
|
3
|
3
|
3
|
|
| Total Current Liabilities |
21
|
29
|
39
|
35
|
33
|
30
|
43
|
40
|
49
|
58
|
|
| Long-Term Debt |
0
|
3
|
2
|
0
|
2
|
4
|
1
|
3
|
4
|
3
|
|
| Deferred Income Tax |
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
|
| Total Liabilities |
21
N/A
|
33
+57%
|
41
+23%
|
36
-12%
|
36
+1%
|
34
-5%
|
44
+30%
|
45
+2%
|
58
+27%
|
65
+12%
|
|
| Equity | |||||||||||
| Common Stock |
2
|
2
|
2
|
33
|
33
|
33
|
35
|
35
|
35
|
35
|
|
| Retained Earnings |
14
|
18
|
17
|
22
|
11
|
14
|
20
|
34
|
28
|
36
|
|
| Other Equity |
0
|
0
|
0
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
15
N/A
|
20
+28%
|
19
-4%
|
39
+108%
|
44
+13%
|
47
+7%
|
55
+16%
|
69
+26%
|
63
-9%
|
71
+13%
|
|
| Total Liabilities & Equity |
36
N/A
|
53
+45%
|
60
+13%
|
75
+26%
|
80
+7%
|
81
+2%
|
99
+22%
|
114
+15%
|
121
+6%
|
136
+12%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
240
|
240
|
240
|
300
|
300
|
300
|
309
|
309
|
309
|
309
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
